Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS

Allogeneic hematopoietic stem cell transplantation remains the best curative option for higher-risk myelodysplastic syndrome. The presence of monosomal karyotype and/or complex karyotype abnormalities predicts inferior survival after allo-SCT in MDS patients. Haploidentical allo-SCT has been increas...

Descripción completa

Detalles Bibliográficos
Autores principales: Michel, Claire, Robin, Marie, Morisset, Stephane, Blaise, Didier, Maertens, Johan, Chevalier, Patrice, Castilla-Llorente, Cristina, Forcade, Edouard, Ceballos, Patrice, Yakoug-Agha, Ibrahim, Poire, Xavier, Carre, Martin, Bay, Jacques-Olivier, Beguin, Yves, Loschi, Michael, Huynh, Anne, Guillerm, Gaëlle, François, Sylvie, Mear, Jean-Baptiste, Duléry, Rémy, Suarez, Felipe, Bilger, Karin, Cornillon, Jérôme, Chalandon, Yves, Maillard, Natacha, Labussière-Wallet, Hélène, Charbonnier, Amandine, Turlure, Pascal, Berceanu, Ana, Chantepie, Sylvain, Maury, Sébastien, Bazarbachi, Ali, Menard, Anne-Lise, Nguyen-Quoc, Stephanie, Rubio, Marie-Thérèse, D’Aveni, Maud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162937/
https://www.ncbi.nlm.nih.gov/pubmed/36774430
http://dx.doi.org/10.1038/s41409-023-01931-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162937/
https://www.ncbi.nlm.nih.gov/pubmed/36774430
http://dx.doi.org/10.1038/s41409-023-01931-7

Ejemplares similares